Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-03-000436
Filing Date
2003-02-14
Accepted
2003-02-14 12:26:56
Documents
3
Group Members
ORBIMED ADVISORS INC.ORBIMED ADVISORS LLCORBIMED CAPITAL LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A sc13ga_021203-incyte.txt SC 13G/A 9910
3 JOINT FILING AGREEMENT ex1-1_021203incyte.txt EX-1.1 2450
4 STATEMENT OF CONTROL PERSON ex2-1_021203incyte.txt EX-2.1 948
  Complete submission text file 0000947871-03-000436.txt   15646
Mailing Address 3160 PORTER DRIVE PALO ALTO CA 94304
Business Address 3160 PORTER DR PALO ALTO CA 94304 6508550555
INCYTE GENOMICS INC (Subject) CIK: 0000879169 (see all company filings)

EIN.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45040 | Film No.: 03564791
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address
Business Address 41 MADISON AVE 40TH FL NEW YORK NY 10010 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE